Medtronic Entering $450 Mil. ENT Market Via $800 Mil. Xomed Acquisition
This article was originally published in The Gray Sheet
Executive Summary
Acquisition of surgical ear nose and throat device maker Xomed Surgical Products under an Aug. 27 merger agreement valued at $800 mil. will mark Medtronic's entrance into the $450 mil. worldwide ENT market.
You may also be interested in...
Urologix Targis BPH Procedure Kit Sales Growth Spurs 38% August Stock Gain
Increased procedure kit sales for use with Urologix' Targis microwave catheter-based system for treatment of benign prostatic hyperplasia helped give the Minneapolis firm's stock a 38% boost in August.
Urologix Targis BPH Procedure Kit Sales Growth Spurs 38% August Stock Gain
Increased procedure kit sales for use with Urologix' Targis microwave catheter-based system for treatment of benign prostatic hyperplasia helped give the Minneapolis firm's stock a 38% boost in August.
Medtronic Banking On S670 Stent, Pipeline For Vascular Business Rebound
U.S. feasibility trials of Medtronic's INX neurovascular stent for the treatment of atherosclerotic vessels in the brain began Aug. 11, the company announced Aug. 23.